Munich - Delayed Quote EUR
Stoke Therapeutics Inc (0GT.MU)
8.60
+0.35
+(4.24%)
At close: 8:04:35 AM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
271,555
228,342
256,067
238,865
Total Liabilities Net Minority Interest
42,534
68,777
71,218
21,088
Total Equity Gross Minority Interest
229,021
159,565
184,849
217,777
Total Capitalization
229,021
159,565
184,849
217,777
Common Stock Equity
229,021
159,565
184,849
217,777
Capital Lease Obligations
2,322
2,062
2,359
1,507
Net Tangible Assets
229,021
159,565
184,849
217,777
Working Capital
192,700
184,520
212,676
212,079
Invested Capital
229,021
159,565
184,849
217,777
Tangible Book Value
229,021
159,565
184,849
217,777
Total Debt
2,322
2,062
2,359
1,507
Share Issued
54,032.83
45,918.23
39,439.58
36,902.50
Ordinary Shares Number
54,032.83
45,918.23
39,439.58
36,902.50
12/31/2021 - 7/15/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DNTH Dianthus Therapeutics, Inc.
21.67
+2.07%
PHVS Pharvaris N.V.
16.84
+6.38%
TRML Tourmaline Bio, Inc.
16.89
-2.48%
COYA Coya Therapeutics, Inc.
6.18
-5.36%
BCYC Bicycle Therapeutics plc
8.42
-2.09%
LTRN Lantern Pharma Inc.
3.5900
-2.18%
IDYA IDEAYA Biosciences, Inc.
19.00
-0.37%
TIL Instil Bio, Inc.
12.78
-34.83%
VERA Vera Therapeutics, Inc.
23.22
-1.07%
ALXO ALX Oncology Holdings Inc.
0.5417
-9.87%